Jung-Yeul Jung

Bio: Jung-Yeul Jung is an academic researcher from Korean Ocean Research and Development Institute. The author has contributed to research in topics: Nanofluid & Thermal conductivity. The author has an hindex of 24, co-authored 82 publications receiving 1975 citations. Previous affiliations of Jung-Yeul Jung include Kyung Hee University & Arizona State University.

CO2 bubble absorption enhancement in methanol-based nanofluids

Abstract: In this study, the nanoparticles (i.e. SiO2 and Al2O3 nanoparticles) and methanol are combined into SiO2/methanol and Al2O3/methanol nanofluids to enhance the CO2 absorption rate of the base fluid (methanol). The absorption experiments are performed in the bubble type absorber system equipped with mass flow controller (MFC), mass flow meter (MFM) and silica gel (which can remove the methanol vapor existing in the outlet gases). The parametric analysis on the effects of the particle species and concentrations on CO2 bubble absorption rate is carried out. The particle concentration ranges from 0.005 to 0.5 vol%. It is found that the CO2 absorption rate is enhanced up to 4.5% at 0.01 vol% of Al2O3/methanol nanofluids at 20 °C, and 5.6% at 0.01 vol% of SiO2/methanol nanofluids at −20 °C, respectively.

CO 2 absorption characteristics of nanoparticle suspensions in methanol

Abstract: Recently there have been growing concerns that anthropogenic carbon dioxide (CO2) emissions cause the global warming problem. Therefore, the cutting-edge technologies for the reduction, separation and collection of the CO2 are very important to alleviate this problem. The best methods for reducing the CO2 emission are to increase the energy efficiency and to remove it from the power plant. The CO2 absorption from the syngas in the integrated gasification combined cycle (IGCC) might increase the energy efficiency of the power generation systems, which also contribute to mitigate the global warming. In this study, the suspensions of nanoparticles in methanol (called the nanofluid) are developed and estimated to apply it to absorb CO2 gas in the IGCC systems. The nanofluids are prepared by the ultrasonic treatment and show the good stability. It is found that the CO2 absorption rate by the nanofluid is enhanced up to ∼8.3% compared to the pure methanol.

A review on applications and challenges of nanofluids

Abstract: Nanofluids are potential heat transfer fluids with enhanced thermophysical properties and heat transfer performance can be applied in many devices for better performances (i.e. energy, heat transfer and other performances). In this paper, a comprehensive literature on the applications and challenges of nanofluids have been compiled and reviewed. Latest up to date literatures on the applications and challenges in terms of PhD and Master thesis, journal articles, conference proceedings, reports and web materials have been reviewed and reported. Recent researches have indicated that substitution of conventional coolants by nanofluids appears promising. Specific application of nanofluids in engine cooling, solar water heating, cooling of electronics, cooling of transformer oil, improving diesel generator efficiency, cooling of heat exchanging devices, improving heat transfer efficiency of chillers, domestic refrigerator-freezers, cooling in machining, in nuclear reactor and defense and space have been reviewed and presented. Authors also critically analyzed some of the applications and identified research gaps for further research. Moreover, challenges and future directions of applications of nanofluids have been reviewed and presented in this paper. Based on results available in the literatures, it has been found nanofluids have a much higher and strongly temperature-dependent thermal conductivity at very low particle concentrations than conventional fluids. This can be considered as one of the key parameters for enhanced performances for many of the applications of nanofluids. Because of its superior thermal performances, latest up to date literatures on this property have been summarized and presented in this paper as well. However, few barriers and challenges that have been identified in this review must be addressed carefully before it can be fully implemented in the industrial applications.

Liquid-infused structured surfaces with exceptional anti-biofouling performance

Abstract: Bacteria primarily exist in robust, surface-associated communities known as biofilms, ubiquitous in both natural and anthropogenic environments. Mature biofilms resist a wide range of antimicrobial treatments and pose persistent pathogenic threats. Treatment of adherent biofilm is difficult, costly, and, in medical systems such as catheters or implants, frequently impossible. At the same time, strategies for biofilm prevention based on surface chemistry treatments or surface microstructure have been found to only transiently affect initial attachment. Here we report that Slippery Liquid-Infused Porous Surfaces (SLIPS) prevent 99.6% of Pseudomonas aeruginosa biofilm attachment over a 7-d period, as well as Staphylococcus aureus (97.2%) and Escherichia coli (96%), under both static and physiologically realistic flow conditions. In contrast, both polytetrafluoroethylene and a range of nanostructured superhydrophobic surfaces accumulate biofilm within hours. SLIPS show approximately 35 times the reduction of attached biofilm versus best case scenario, state-of-the-art PEGylated surface, and over a far longer timeframe. We screen for and exclude as a factor cytotoxicity of the SLIPS liquid, a fluorinated oil immobilized on a structured substrate. The inability of biofilm to firmly attach to the surface and its effective removal under mild flow conditions (about 1 cm/s) are a result of the unique, nonadhesive, “slippery” character of the smooth liquid interface, which does not degrade over the experimental timeframe. We show that SLIPS-based antibiofilm surfaces are stable in submerged, extreme pH, salinity, and UV environments. They are low-cost, passive, simple to manufacture, and can be formed on arbitrary surfaces. We anticipate that our findings will enable a broad range of antibiofilm solutions in the clinical, industrial, and consumer spaces.